Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
Authors:
- 23 May 2009
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 30 (3) , 309-315
Abstract
We studied the influence of IL-6 on chemokine production from peripheral blood mononuclear cells (PBMC), fibroblastic synovial cells and human umbilical vessel endothelial cells (HUVEC). Moreover, we examined the effect of IL-6 on the adhesion of U937 cells to HUVEC. For chemokine production, PBMC, fibroblastic synovial cells and HUVEC were cultured with IL-6 or IL-6 + soluble IL-6R (sIL-6R) for 24 h and then the production of MCP-1 and IL-8 were measured in supernatants. IL-6 and IL-6 + sIL-6R induced production of both MCP-1 and IL-8 in PBMC and synovial cells, respectively. In HUVEC, IL-6 + sIL-6R induced MCP-1 production, but inhibited IL-8 production. For adhesion molecule expression, the production of soluble form of adhesion molecules in HUVEC culture supernatant were measured by ELISA and the expression of adhesion molecules on cell surface were examined by flow cytometry analysis. Soluble ICAM-1 was detectable in IL-6 + sIL-6R-treated HUVEC and IL-6 + sIL-6R-induced ICAM-1 expression on cell membrane of HUVEC. In addition, U937 cells were added to HUVEC, which were pre-treated with IL-6 + sIL-6R for 24 h, and 3 h later attached U937 cells were counted. The adhesion of U937 cells to HUVEC was augmented when HUVEC was pretreated by IL-6 + sIL-6R. This adhesion was suppressed by anti-ICAM-1 antibody and anti-IL-6R antibody, but not by antibodies against VCAM-1 or E-selectin. In conclusion, IL-6 signaling plays an important role in inflammatory cell migration by increasing the rate of cell adhesion and by inducing chemokine production in inflamed joints.Keywords
This publication has 19 references indexed in Scilit:
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialThe Lancet, 2008
- Soluble cell adhesion molecules (sICAM‐1, sVCAM‐1, and sE‐selectin) in patients with early rheumatoid arthritisScandinavian Journal of Rheumatology, 2007
- Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte RecruitmentImmunity, 1997
- Soluble Intercellular Adhesion Molecule‐1 (ICAM‐1) Antigen in Patients with Rheumatoid ArthritisScandinavian Journal of Immunology, 1993
- Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.Journal of Clinical Investigation, 1992
- Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cellsBiochemical and Biophysical Research Communications, 1992
- Evidence for the involvement of carbohydrate moieties in the adhesion of U937 cells to tumor necrosis factor-α (TNFα)-stimulated vascular endotheliumin vitroInflammation Research, 1991
- Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.Journal of Clinical Investigation, 1991
- Modulation of U937 cell adhesion to vascular endothelial cells by cyclic AMPLife Sciences, 1991
- Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritidesArthritis & Rheumatism, 1988